Dr. Kerry Rogers is an Associate Professor with tenure in the Division of Hematology at The Ohio State University and specializes in Chronic Lymphocytic Leukemia (CLL) and Hairy Cell Leukemia (HCL). She is a physician-scientist working on chemotherapy-free combinations to improve the use of BTK inhibitors. She leads clinical trials studying novel regimens for CLL and conducts translation work in the Experimental Hematology Laboratory. Her research interests include BTKi combination, complications of targeted therapy for CLL, management of Richter’s syndrome, and autoimmune hemolytic anemia.